{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T05:14:09Z","timestamp":1763788449441,"version":"3.45.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03090-9","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:38:31Z","timestamp":1761291511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing the role of transforming growth factor-\u03b2 in glioblastoma: a focus on phytochemicals"],"prefix":"10.1007","volume":"42","author":[{"given":"Ali","family":"Nakhaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Mohtashami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Jalili-Nik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir R.","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"3090_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216955","volume":"593","author":"AR Afshari","year":"2024","unstructured":"Afshari AR, et al. Nature\u2019s arsenal: harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: an especial attention to brain malignancies. Cancer Lett. 2024;593:216955.","journal-title":"Cancer Lett"},{"key":"3090_CR2","first-page":"1","volume":"2025","author":"AR Afshari","year":"2025","unstructured":"Afshari AR, et al. A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules. Inflammopharmacology. 2025;2025:1\u201318.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"3090_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/0929867327666200130104757","volume":"28","author":"AR Afshari","year":"2021","unstructured":"Afshari AR, et al. Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway. Curr Med Chem. 2021;28(2):377\u2013400.","journal-title":"Curr Med Chem"},{"key":"3090_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113740","volume":"155","author":"M Sanati","year":"2022","unstructured":"Sanati M, et al. Recent advances in glioblastoma multiforme therapy: a focus on autophagy regulation. Biomed Pharmacother. 2022;155:113740.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"3090_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1389200221666200714101038","volume":"21","author":"E Mohtashami","year":"2020","unstructured":"Mohtashami E, et al. The current state of potential therapeutic modalities for glioblastoma multiforme: a clinical review. Curr Drug Metab. 2020;21(8):564\u201378.","journal-title":"Curr Drug Metab"},{"issue":"7","key":"3090_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cells14070494","volume":"14","author":"J Tang","year":"2025","unstructured":"Tang J, Karbhari N, Campian JL. Therapeutic targets in glioblastoma: molecular pathways, emerging strategies, and future directions. Cells. 2025;14(7):494.","journal-title":"Cells"},{"issue":"2","key":"3090_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/ijms25021067","volume":"25","author":"I Gol\u00e1n-Cancela","year":"2024","unstructured":"Gol\u00e1n-Cancela I, Caja L. The TGF-\u03b2 family in glioblastoma. Int J Mol Sci. 2024;25(2):1067.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3090_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/138161206775201901","volume":"12","author":"W Wick","year":"2006","unstructured":"Wick W, Naumann U, Weller M. Transforming growth factor-\u03b2: a molecular target for the future therapy of glioblastoma. Curr Pharm Des. 2006;12(3):341\u20139.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"3090_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.stem.2009.08.018","volume":"5","author":"H Ikushima","year":"2009","unstructured":"Ikushima H, et al. Autocrine TGF-\u03b2 signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell. 2009;5(5):504\u201314.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"3090_CR10","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.febslet.2006.04.033","volume":"580","author":"J Massagu\u00e9","year":"2006","unstructured":"Massagu\u00e9 J, Gomis RR. The logic of TGF\u03b2 signaling. FEBS Lett. 2006;580(12):2811\u201320.","journal-title":"FEBS Lett"},{"issue":"2","key":"3090_CR11","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/ol.2016.4756","volume":"12","author":"I Bryukhovetskiy","year":"2016","unstructured":"Bryukhovetskiy I, Shevchenko V. Molecular mechanisms of the effect of TGF-\u03b21 on U87 human glioblastoma cells. Oncol Lett. 2016;12(2):1581\u201390.","journal-title":"Oncol Lett"},{"key":"3090_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-018-1423-8","volume":"8","author":"BR Sharma","year":"2018","unstructured":"Sharma BR, et al. Microbial maceration: a sustainable approach for phytochemical extraction. 3 Biotech. 2018;8:1\u201313.","journal-title":"3 Biotech"},{"key":"3090_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109638","volume":"72","author":"JL Birch","year":"2020","unstructured":"Birch JL, et al. Multifaceted transforming growth factor-beta (TGF\u03b2) signalling in glioblastoma. Cell Signal. 2020;72:109638.","journal-title":"Cell Signal"},{"issue":"1","key":"3090_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010015","volume":"17","author":"I Salazar-Saura","year":"2024","unstructured":"Salazar-Saura I, et al. Pericytes in glioblastoma: hidden regulators of tumor vasculature and therapy resistance. Cancers (Basel). 2024;17(1):15.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3090_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105072","volume":"25","author":"M Martinez-Morga","year":"2024","unstructured":"Martinez-Morga M, et al. Pericytes are immunoregulatory cells in glioma genesis and progression. Int J Mol Sci. 2024;25(10):5072.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3090_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010214","volume":"11","author":"L Schumacher","year":"2023","unstructured":"Schumacher L, et al. TGF-beta modulates the integrity of the blood brain barrier in vitro, and is associated with metabolic alterations in pericytes. Biomedicines. 2023;11(1):214.","journal-title":"Biomedicines"},{"key":"3090_CR17","first-page":"4","volume":"5","author":"L Merk","year":"2024","unstructured":"Merk L, et al. Blocking TGF-\u03b2-and epithelial-to-mesenchymal transition (EMT)-mediated activation of vessel-associated mural cells in glioblastoma impacts tumor angiogenesis. Free Neuropathol. 2024;5:4.","journal-title":"Free Neuropathol"},{"issue":"6","key":"3090_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/nan.12714","volume":"47","author":"NM Wirsik","year":"2021","unstructured":"Wirsik NM, et al. TGF-\u03b2 activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma. Neuropathol Appl Neurobiol. 2021;47(6):768\u201380.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"54","key":"3090_CR19","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1038\/onc.2008.287","volume":"27","author":"A Pen","year":"2008","unstructured":"Pen A, et al. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-\u03b2 signaling. Oncogene. 2008;27(54):6834\u201344.","journal-title":"Oncogene"},{"issue":"3","key":"3090_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/path.4072","volume":"228","author":"LC Dieterich","year":"2012","unstructured":"Dieterich LC, et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF\u03b22 in vascular abnormalization. J Pathol. 2012;228(3):378\u201390.","journal-title":"J Pathol"},{"issue":"7","key":"3090_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.onc.1210683","volume":"27","author":"A Wesolowska","year":"2008","unstructured":"Wesolowska A, et al. Microglia-derived TGF-\u03b2 as an important regulator of glioblastoma invasion\u2014an inhibition of TGF-\u03b2-dependent effects by shRNA against human TGF-\u03b2 type II receptor. Oncogene. 2008;27(7):918\u201330.","journal-title":"Oncogene"},{"key":"3090_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.108960","volume":"317","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K\/Akt pathway. Chem Biol Interact. 2020;317:108960.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"3090_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/noab212","volume":"24","author":"JV Joseph","year":"2022","unstructured":"Joseph JV, et al. TGF-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1. Neuro-oncol. 2022;24(4):541\u201353.","journal-title":"Neuro-oncol"},{"issue":"2","key":"3090_CR24","doi-asserted-by":"publisher","DOI":"10.1063\/5.0203213","volume":"8","author":"KY Amofa","year":"2024","unstructured":"Amofa KY, et al. Dissecting TGF-\u03b2-induced glioblastoma invasion with engineered hyaluronic acid hydrogels. APL Bioeng. 2024;8(2):026125.","journal-title":"APL Bioeng"},{"issue":"2","key":"3090_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccr.2006.11.023","volume":"11","author":"A Bruna","year":"2007","unstructured":"Bruna A, et al. High TGF\u03b2-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell. 2007;11(2):147\u201360.","journal-title":"Cancer Cell"},{"issue":"10","key":"3090_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1290\/1071-2690(2001)037<0684:TROTTG>2.0.CO;2","volume":"37","author":"M Kingsley-Kallesen","year":"2001","unstructured":"Kingsley-Kallesen M, Luster TA, Rizzino A. Transcriptional regulation of the transforming growth factor-\u03b22 gene in glioblastoma cells. In Vitro Cell Dev Biol Anim. 2001;37(10):684\u201390.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"14","key":"3090_CR27","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.febslet.2015.04.058","volume":"589","author":"L Caja","year":"2015","unstructured":"Caja L, Bellomo C, Moustakas A. Transforming growth factor \u03b2 and bone morphogenetic protein actions in brain tumors. FEBS Lett. 2015;589(14):1588\u201397.","journal-title":"FEBS Lett"},{"issue":"8","key":"3090_CR28","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.4049\/jimmunol.150.8.3109","volume":"150","author":"SS Ahuja","year":"1993","unstructured":"Ahuja SS, et al. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol. 1993;150(8):3109\u201318.","journal-title":"J Immunol"},{"key":"3090_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-009-9884-6","volume":"93","author":"A Ksendzovsky","year":"2009","unstructured":"Ksendzovsky A, et al. Investigation of immunosuppressive mechanisms in a mouse glioma model. J Neurooncol. 2009;93:107\u201314.","journal-title":"J Neurooncol"},{"issue":"10","key":"3090_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/eji.1830181023","volume":"18","author":"P Zuber","year":"1988","unstructured":"Zuber P, Kuppner MC, Tribolet ND. Transforming growth factor-\u03b22 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol. 1988;18(10):1623\u20136.","journal-title":"Eur J Immunol"},{"issue":"21","key":"3090_CR31","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/1078-0432.CCR-09-1067","volume":"15","author":"R Ueda","year":"2009","unstructured":"Ueda R, et al. Systemic inhibition of transforming growth factor-\u03b2 in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Clin Cancer Res. 2009;15(21):6551\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3090_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/nop009","volume":"12","author":"CA Crane","year":"2010","unstructured":"Crane CA, et al. TGF-\u03b2 downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol. 2010;12(1):7\u201313.","journal-title":"Neuro Oncol"},{"issue":"A","key":"3090_CR33","first-page":"133","volume":"10","author":"GG Gomez","year":"2006","unstructured":"Gomez GG, Kruse CA. Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther Mol Biol. 2006;10(A):133.","journal-title":"Gene Ther Mol Biol"},{"issue":"11","key":"3090_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","volume":"12","author":"A Wu","year":"2010","unstructured":"Wu A, et al. Glioma cancer stem cells induce immunosuppressive macrophages\/microglia. Neuro Oncol. 2010;12(11):1113\u201325.","journal-title":"Neuro Oncol"},{"issue":"2","key":"3090_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3171\/2014.4.JNS131198","volume":"121","author":"B Thota","year":"2014","unstructured":"Thota B, et al. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. J Neurosurg. 2014;121(2):374\u201383.","journal-title":"J Neurosurg"},{"key":"3090_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-018-0273-7","volume":"16","author":"CR Oliva","year":"2018","unstructured":"Oliva CR, et al. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2\/IGF-1R signaling. Cell Commun Signal. 2018;16:1\u201314.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3090_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/07357907.2011.630050","volume":"30","author":"H Mao","year":"2012","unstructured":"Mao H, et al. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest. 2012;30(1):48\u201356.","journal-title":"Cancer Invest"},{"issue":"11","key":"3090_CR38","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.cellsig.2013.07.007","volume":"25","author":"R Samarakoon","year":"2013","unstructured":"Samarakoon R, et al. Induction of renal fibrotic genes by TGF-\u03b21 requires EGFR activation, p53 and reactive oxygen species. Cell Signal. 2013;25(11):2198\u2013209.","journal-title":"Cell Signal"},{"issue":"6","key":"3090_CR39","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1158\/1055-9965.EPI-09-1213","volume":"19","author":"V Santosh","year":"2010","unstructured":"Santosh V, et al. Grade-Specific Expression of Insulin-like Growth Factor-Binding Proteins-2,-3, and-5 in Astrocytomas: IGFBP-3 Emerges as a Strong Predictor of Survival in Patients with Newly Diagnosed Glioblastoma. Cancer Epidemiol Biomark Prev. 2010;19(6):1399\u2013408.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"36","key":"3090_CR40","doi-asserted-by":"publisher","first-page":"25079","DOI":"10.1074\/jbc.M114.593863","volume":"289","author":"CH Yang","year":"2014","unstructured":"Yang CH, et al. Microrna-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). J Biol Chem. 2014;289(36):25079\u201387.","journal-title":"J Biol Chem"},{"issue":"5","key":"3090_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106639","volume":"26","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. IGFBP3 induced by the TGF-\u03b2\/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma. IScience. 2023;26(5):106639.","journal-title":"IScience"},{"issue":"3","key":"3090_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/neuonc\/noaa198","volume":"23","author":"E Nie","year":"2021","unstructured":"Nie E, et al. TGF-\u03b21 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT. Neuro-oncol. 2021;23(3):435\u201346.","journal-title":"Neuro-oncol"},{"issue":"6","key":"3090_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.248","volume":"8","author":"H Zeng","year":"2017","unstructured":"Zeng H, et al. Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-\u03b21-dependent activation of Smad\/ERK signaling. Cell Death Dis. 2017;8(6):e2885\u2013e2885.","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"3090_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2006.02.019","volume":"246","author":"L Bartholin","year":"2007","unstructured":"Bartholin L, et al. The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett. 2007;246(1\u20132):230\u20136.","journal-title":"Cancer Lett"},{"key":"3090_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2018.10.034","volume":"442","author":"NI Mar\u00edn-Ramos","year":"2019","unstructured":"Mar\u00edn-Ramos NI, et al. NEO212, a conjugate of temozolomide and perillyl alcohol, blocks the endothelial-to-mesenchymal transition in tumor-associated brain endothelial cells in glioblastoma. Cancer Lett. 2019;442:170\u201380.","journal-title":"Cancer Lett"},{"issue":"18","key":"3090_CR46","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.18632\/oncotarget.26733","volume":"10","author":"A Xiao","year":"2019","unstructured":"Xiao A, et al. Statins affect human glioblastoma and other cancers through TGF-\u03b2 inhibition. Oncotarget. 2019;10(18):1716.","journal-title":"Oncotarget"},{"issue":"23","key":"3090_CR47","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1158\/0008-5472.CAN-11-1212","volume":"71","author":"M Zhang","year":"2011","unstructured":"Zhang M, et al. Blockade of TGF-\u03b2 signaling by the TGF\u03b2R-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma. Can Res. 2011;71(23):7155\u201367.","journal-title":"Can Res"},{"issue":"21","key":"3090_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167049","volume":"8","author":"H-M Jeon","year":"2023","unstructured":"Jeon H-M, et al. The semaphorin 3A\/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-\u03b2 signaling. JCI Insight. 2023;8(21):e167049.","journal-title":"JCI Insight"},{"key":"3090_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.723798","volume":"12","author":"A Chisari","year":"2021","unstructured":"Chisari A, et al. Glucose and amino acid metabolic dependencies linked to stemness and metastasis in different aggressive cancer types. Front Pharmacol. 2021;12:723798.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3090_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5549047","volume":"2021","author":"X Su","year":"2021","unstructured":"Su X, et al. NOX4-derived ROS mediates TGF-\u03b21-induced metabolic reprogramming during epithelial-mesenchymal transition through the PI3K\/AKT\/HIF-1\u03b1 pathway in glioblastoma. Oxid Med Cell Longev. 2021;2021(1):5549047.","journal-title":"Oxid Med Cell Longev"},{"key":"3090_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577633","volume":"357","author":"R Chaudhary","year":"2021","unstructured":"Chaudhary R, Morris RJ, Steinson E. The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma. J Neuroimmunol. 2021;357:577633.","journal-title":"J Neuroimmunol"},{"key":"3090_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142116","author":"H Shaim","year":"2021","unstructured":"Shaim H, et al. Targeting the \u03b1v integrin\/TGF-\u03b2 axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI142116.","journal-title":"J Clin Invest"},{"issue":"4","key":"3090_CR53","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"10","key":"3090_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.395","volume":"5","author":"JV Joseph","year":"2014","unstructured":"Joseph JV, et al. TGF-\u03b2 is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis. 2014;5(10):e1443.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3090_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/19336918.2014.983794","volume":"9","author":"E-J Tan","year":"2015","unstructured":"Tan E-J, Olsson A-K, Moustakas A. Reprogramming during epithelial to mesenchymal transition under the control of TGF\u03b2. Cell adhesion migr. 2015;9(3):233\u201346.","journal-title":"Cell adhesion migr"},{"issue":"8","key":"3090_CR56","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1080\/15384101.2016.1152432","volume":"15","author":"R Wahdan-Alaswad","year":"2016","unstructured":"Wahdan-Alaswad R, et al. Metformin attenuates transforming growth factor beta (TGF-\u03b2) mediated oncogenesis in mesenchymal stem-like\/claudin-low triple negative breast cancer. Cell Cycle. 2016;15(8):1046\u201359.","journal-title":"Cell Cycle"},{"issue":"4","key":"3090_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04788-8","volume":"13","author":"T Yan","year":"2022","unstructured":"Yan T, et al. TGF-\u03b2 induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-\u03b1\/NF-\u03baB signal pathway. Cell Death Dis. 2022;13(4):339.","journal-title":"Cell Death Dis"},{"key":"3090_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.carbpol.2015.04.057","volume":"129","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Macquarrie D. Microwave assisted extraction of sulfated polysaccharides (fucoidan) from Ascophyllum nodosum and its antioxidant activity. Carbohydr Polym. 2015;129:101\u20137.","journal-title":"Carbohydr Polym"},{"key":"3090_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbi.2019.05.003","volume":"85","author":"AB da Silva","year":"2020","unstructured":"da Silva AB, et al. The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity. Brain Behav Immun. 2020;85:170\u201385.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3090_CR60","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/21655979.2019.1632669","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, et al. Epigallocatechin gallate (EGCG) suppresses epithelial-mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-\u03b21\/Smad signaling pathways. Bioengineered. 2019;10(1):282\u201391.","journal-title":"Bioengineered"},{"key":"3090_CR61","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbi.2016.11.022","volume":"261","author":"AA Ganai","year":"2017","unstructured":"Ganai AA, Husain M. Genistein attenuates D-GalN induced liver fibrosis\/chronic liver damage in rats by blocking the TGF-\u03b2\/Smad signaling pathways. Chem Biol Interact. 2017;261:80\u20135.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"3090_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3892\/or.2017.5676","volume":"38","author":"X-F Liu","year":"2017","unstructured":"Liu X-F, et al. Fisetin inhibits liver cancer growth in a mouse model: relation to dopamine receptor. Oncol Rep. 2017;38(1):53\u201362.","journal-title":"Oncol Rep"},{"issue":"9","key":"3090_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091271","volume":"11","author":"K-Y Huang","year":"2021","unstructured":"Huang K-Y, et al. Growth suppression in lung cancer cells harboring EGFR-C797S mutation by quercetin. Biomolecules. 2021;11(9):1271.","journal-title":"Biomolecules"},{"key":"3090_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11010-020-03885-6","volume":"476","author":"P Rajendran","year":"2021","unstructured":"Rajendran P, et al. Myricetin: versatile plant based flavonoid for cancer treatment by inducing cell cycle arrest and ROS\u2013reliant mitochondria-facilitated apoptosis in A549 lung cancer cells and in silico prediction. Mol Cell Biochem. 2021;476:57\u201368.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3090_CR65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2018.02.044","volume":"498","author":"J Feng","year":"2018","unstructured":"Feng J, et al. Quercetin restrains TGF-\u03b21-induced epithelial\u2013mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression. Biochem Biophys Res Commun. 2018;498(1):132\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"3090_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1361-2","volume":"38","author":"C Wang","year":"2019","unstructured":"Wang C, et al. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J Exp Clin Cancer Res. 2019;38:1\u201314.","journal-title":"J Exp Clin Cancer Res"},{"key":"3090_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10565-007-9017-y","volume":"24","author":"AR Silva","year":"2008","unstructured":"Silva AR, et al. The flavonoid rutin induces astrocyte and microglia activation and regulates TNF-alpha and NO release in primary glial cell cultures. Cell Biol Toxicol. 2008;24:75\u201386.","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"3090_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.37796\/2211-8039.1447","volume":"14","author":"P Rajendran","year":"2024","unstructured":"Rajendran P. Unveiling the power of flavonoids: a dynamic exploration of their impact on cancer through matrix metalloproteinases regulation. Biomedicine. 2024;14(2):12.","journal-title":"Biomedicine"},{"issue":"6","key":"3090_CR69","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jn\/136.6.1477","volume":"136","author":"R Schindler","year":"2006","unstructured":"Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr. 2006;136(6):1477\u201382.","journal-title":"J Nutr"},{"issue":"6","key":"3090_CR70","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ptr.3338","volume":"25","author":"S Freitas","year":"2011","unstructured":"Freitas S, et al. Flavonoids inhibit angiogenic cytokine production by human glioma cells. Phytother Res. 2011;25(6):916\u201321.","journal-title":"Phytother Res"},{"issue":"3","key":"3090_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu8030167","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y, et al. Quercetin, inflammation and immunity. Nutrients. 2016;8(3):167.","journal-title":"Nutrients"},{"key":"3090_CR72","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.2147\/DDDT.S185618","volume":"12","author":"W Cai","year":"2018","unstructured":"Cai W, et al. Quercetin inhibits transforming growth factor \u03b21-induced epithelial\u2013mesenchymal transition in human retinal pigment epithelial cells via the Smad pathway. Drug Des Dev Ther. 2018;12:4149\u201361.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"3090_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4393266","volume":"2021","author":"P Asgharian","year":"2021","unstructured":"Asgharian P, et al. Quercetin impact in pancreatic cancer: an overview on its therapeutic effects. Oxid Med Cell Longev. 2021;2021(1):4393266.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"3090_CR74","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i2.189","volume":"7","author":"G di Camillo Orfali","year":"2016","unstructured":"di Camillo Orfali G, et al. Review of anticancer mechanisms of isoquercitin. World J Clin Oncol. 2016;7(2):189.","journal-title":"World J Clin Oncol"},{"issue":"3","key":"3090_CR75","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/neuonc\/nou161","volume":"17","author":"AM Mikheev","year":"2015","unstructured":"Mikheev AM, et al. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. Neuro Oncol. 2015;17(3):372\u201382.","journal-title":"Neuro Oncol"},{"issue":"7","key":"3090_CR76","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ptr.6057","volume":"32","author":"J Zhu","year":"2018","unstructured":"Zhu J, Wen K. Astragaloside IV inhibits TGF-\u03b21-induced epithelial-mesenchymal transition through inhibition of the PI3K\/Akt\/NF-\u03baB pathway in gastric cancer cells. Phytother Res. 2018;32(7):1289\u201396.","journal-title":"Phytother Res"},{"issue":"4","key":"3090_CR77","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12849","volume":"32","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-\u03b2\/Smad signaling pathway. Dermatol Ther. 2019;32(4):e12802.","journal-title":"Dermatol Ther"},{"key":"3090_CR78","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s11064-018-2478-y","volume":"43","author":"Z Wang","year":"2018","unstructured":"Wang Z, et al. Paeoniflorin inhibits migration and invasion of human glioblastoma cells via suppression transforming growth factor \u03b2-induced epithelial\u2013mesenchymal transition. Neurochem Res. 2018;43:760\u201374.","journal-title":"Neurochem Res"},{"issue":"2","key":"3090_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neulet.2006.11.039","volume":"413","author":"X Li","year":"2007","unstructured":"Li X, et al. Expression of TGF-\u03b2s and TGF-\u03b2 type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. Neurosci Lett. 2007;413(2):141\u20134.","journal-title":"Neurosci Lett"},{"issue":"8","key":"3090_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160979","volume":"11","author":"E Navarro-Villar\u00e1n","year":"2016","unstructured":"Navarro-Villar\u00e1n E, et al. Differential antitumoral properties and renal-associated tissue damage induced by tacrolimus and mammalian target of rapamycin inhibitors in hepatocarcinoma: in vitro and in vivo studies. PLoS ONE. 2016;11(8):e0160979.","journal-title":"PLoS ONE"},{"issue":"6","key":"3090_CR81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s13238-011-1056-8","volume":"2","author":"L Qin","year":"2011","unstructured":"Qin L, et al. Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell. 2011;2(6):507\u201316.","journal-title":"Protein Cell"},{"key":"3090_CR82","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1012209518843","volume":"53","author":"W Wick","year":"2001","unstructured":"Wick W, Platten M, Weller M. Glioma cell invasion: regulation of metalloproteinase activity by TGF-\u03b2. J Neurooncol. 2001;53:177\u201385.","journal-title":"J Neurooncol"},{"key":"3090_CR83","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221130303","volume":"21","author":"Y Jin","year":"2022","unstructured":"Jin Y, et al. Berberine suppressed the progression of human glioma cells by inhibiting the TGF-\u03b21\/SMAD2\/3 signaling pathway. Integr Cancer Ther. 2022;21:15347354221130303.","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"3090_CR84","first-page":"2241","volume":"13","author":"Y Lin","year":"2020","unstructured":"Lin Y, et al. Tetrandrine suppresses the TGF-\u03b21-induced proliferation and migration of airway smooth muscle cells using the Nrf2-ARE signaling pathway. Int J Clin Exp Med. 2020;13(4):2241\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"3090_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/153303461000900109","volume":"9","author":"M Mei","year":"2010","unstructured":"Mei M, et al. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technol Cancer Res Treat. 2010;9(1):77\u201386.","journal-title":"Technol Cancer Res Treat"},{"issue":"04","key":"3090_CR86","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1142\/S0192415X19500484","volume":"47","author":"F-T Hsu","year":"2019","unstructured":"Hsu F-T, et al. Amentoflavone effectively blocked the tumor progression of glioblastoma via suppression of ERK\/NF-\u03ba b signaling pathway. Am J Chin Med. 2019;47(04):913\u201331.","journal-title":"Am J Chin Med"},{"issue":"11","key":"3090_CR87","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/nu10111756","volume":"10","author":"C Ceci","year":"2018","unstructured":"Ceci C, et al. Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid. Nutrients. 2018;10(11):1756.","journal-title":"Nutrients"},{"key":"3090_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108840","volume":"213","author":"Y Sugiyama","year":"2021","unstructured":"Sugiyama Y, et al. Capsaicin attenuates TGF\u03b22-induced epithelial-mesenchymal-transition in lens epithelial cells in vivo and in vitro. Exp Eye Res. 2021;213:108840.","journal-title":"Exp Eye Res"},{"issue":"1","key":"3090_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02663-2","volume":"22","author":"Z Javed","year":"2022","unstructured":"Javed Z, et al. Myricetin: targeting signaling networks in cancer and its implication in chemotherapy. Cancer Cell Int. 2022;22(1):239.","journal-title":"Cancer Cell Int"},{"key":"3090_CR90","first-page":"767","volume":"10","author":"X-H Nie","year":"2016","unstructured":"Nie X-H, et al. Calycosin inhibits migration and invasion through modulation of transforming growth factor beta-mediated mesenchymal properties in U87 and U251 cells. Drug Des Dev Ther. 2016;10:767\u201379.","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"3090_CR91","first-page":"355","volume":"23","author":"Q Yang","year":"2021","unstructured":"Yang Q, et al. Neuroprotective effects of isoquercetin: an in vitro and in vivo study. Cell J. 2021;23(3):355.","journal-title":"Cell J"},{"key":"3090_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/16546628.2017.1361779","volume":"61","author":"HE Khoo","year":"2017","unstructured":"Khoo HE, et al. Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res. 2017;61:1361779.","journal-title":"Food Nutr Res"},{"key":"3090_CR93","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1021\/jf050565k","volume":"53","author":"U Vrhovsek","year":"2005","unstructured":"Vrhovsek U, Mattivi F, Vanzo A. Fast access of some grape pigments to the brain. J Agric Food Chem. 2005;53:7029.","journal-title":"J Agric Food Chem"},{"key":"3090_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113128","volume":"151","author":"C-F Wu","year":"2022","unstructured":"Wu C-F, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3090_CR95","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/mc.22575","volume":"56","author":"A Ouanouki","year":"2017","unstructured":"Ouanouki A, Lamy S, Annabi B. Anthocyanidins inhibit epithelial\u2013mesenchymal transition through a TGF\u03b2\/Smad2 signaling pathway in glioblastoma cells. Mol Carcinog. 2017;56(3):1088\u201399.","journal-title":"Mol Carcinog"},{"issue":"2","key":"3090_CR96","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/brain\/aws351","volume":"136","author":"P Roth","year":"2013","unstructured":"Roth P, et al. Integrin control of the transforming growth factor-\u03b2 pathway in glioblastoma. Brain. 2013;136(2):564\u201376.","journal-title":"Brain"},{"issue":"2","key":"3090_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/molecules21020169","volume":"21","author":"S Afrin","year":"2016","unstructured":"Afrin S, et al. Chemopreventive and therapeutic effects of edible berries: a focus on colon cancer prevention and treatment. Molecules. 2016;21(2):169.","journal-title":"Molecules"},{"issue":"31","key":"3090_CR98","doi-asserted-by":"publisher","first-page":"22023","DOI":"10.18632\/oncotarget.25153","volume":"9","author":"A Ouanouki","year":"2018","unstructured":"Ouanouki A, Lamy S, Annabi B. Periostin, a signal transduction intermediate in TGF-\u03b2-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins. Oncotarget. 2018;9(31):22023.","journal-title":"Oncotarget"},{"issue":"4","key":"3090_CR99","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S2095-4964(14)60038-8","volume":"12","author":"C-Q Ling","year":"2014","unstructured":"Ling C-Q, Yue X-Q, Ling C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J Integr Med. 2014;12(4):331\u20135.","journal-title":"J Integr Med"},{"issue":"1","key":"3090_CR100","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11033-019-05146-2","volume":"47","author":"H Wang","year":"2020","unstructured":"Wang H, et al. IFITM3\/STAT3 axis promotes glioma cells invasion and is modulated by TGF-\u03b2. Mol Biol Rep. 2020;47(1):433\u201341.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3090_CR101","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1139\/bcb-2020-0026","volume":"99","author":"Y He","year":"2021","unstructured":"He Y, et al. Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT\/NF-\u03baB signaling pathway. Biochem Cell Biol. 2021;99(2):214\u201322.","journal-title":"Biochem Cell Biol"},{"issue":"5","key":"3090_CR102","first-page":"2975","volume":"41","author":"L Zhang","year":"2019","unstructured":"Zhang L, et al. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF-\u03b21-mediated PI3K and MAPK pathways. Oncol Rep. 2019;41(5):2975\u201386.","journal-title":"Oncol Rep"},{"issue":"1","key":"3090_CR103","doi-asserted-by":"publisher","first-page":"1698379","DOI":"10.1155\/2016\/1698379","volume":"2016","author":"J Lin","year":"2016","unstructured":"Lin J, et al. Paeoniflorin attenuated oxidative stress in rat COPD model induced by cigarette smoke. Evid Based Complement Altern Med. 2016;2016(1):1698379.","journal-title":"Evid Based Complement Altern Med"},{"key":"3090_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112800","volume":"149","author":"XZ Wang","year":"2022","unstructured":"Wang XZ, et al. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: state-of-the-art. Biomed Pharmacother. 2022;149:112800.","journal-title":"Biomed Pharmacother"},{"key":"3090_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109091","volume":"117","author":"J Choi","year":"2019","unstructured":"Choi J, et al. Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer. Biomed Pharmacother. 2019;117:109091.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3090_CR106","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/molecules25010192","volume":"25","author":"Y Yan","year":"2020","unstructured":"Yan Y, et al. Inhibition of TGF-\u03b2 signaling in gliomas by the flavonoid diosmetin isolated from Dracocephalum peregrinum L. Molecules. 2020;25(1):192.","journal-title":"Molecules"},{"issue":"12","key":"3090_CR107","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/nu15122795","volume":"15","author":"Q Huang","year":"2023","unstructured":"Huang Q, et al. Natural products for the immunotherapy of glioma. Nutrients. 2023;15(12):2795.","journal-title":"Nutrients"},{"issue":"5","key":"3090_CR108","first-page":"1049","volume":"5","author":"M Katayama","year":"1994","unstructured":"Katayama M, et al. Soluble fragments of e-cadherin cell-adhesion molecule increase in urinary-excretion of cancer-patients, potentially indicating its shedding from epithelial tumor-cells. Int J Oncol. 1994;5(5):1049\u201357.","journal-title":"Int J Oncol"},{"issue":"7","key":"3090_CR109","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/cgt.2013.36","volume":"20","author":"S Min","year":"2013","unstructured":"Min S, et al. The glioma-associated oncogene homolog 1 promotes epithelial\u2013mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via snail. Cancer Gene Ther. 2013;20(7):379\u201385.","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"3090_CR110","first-page":"1744","volume":"33","author":"L Liu","year":"2013","unstructured":"Liu L, et al. Transforming growth factor \u03b21 enhances the invasiveness of human glioma cell line via ERK\/MAPK pathway. J South Med Univ. 2013;33(12):1744\u20137.","journal-title":"J South Med Univ"},{"issue":"14","key":"3090_CR111","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/ijms20143380","volume":"20","author":"A Nakajima","year":"2019","unstructured":"Nakajima A, Ohizumi Y. Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer\u2019s disease and Parkinson\u2019s disease. Int J Mol Sci. 2019;20(14):3380.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3090_CR112","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1172\/JCI76725","volume":"126","author":"JE Larsen","year":"2016","unstructured":"Larsen JE, et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J Clin Invest. 2016;126(9):3219\u201335.","journal-title":"J Clin Invest"},{"issue":"5","key":"3090_CR113","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1750-3639.2012.00571.x","volume":"22","author":"M Nagaishi","year":"2012","unstructured":"Nagaishi M, et al. Transcriptional factors for epithelial\u2013mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma. Brain Pathol. 2012;22(5):670\u20136.","journal-title":"Brain Pathol"},{"issue":"5","key":"3090_CR114","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3892\/or.2017.5522","volume":"37","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. Nobiletin inhibits invasion via inhibiting AKT\/GSK3\u03b2\/\u03b2-catenin signaling pathway in Slug-expressing glioma cells. Oncol Rep. 2017;37(5):2847\u201356.","journal-title":"Oncol Rep"},{"key":"3090_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-020-00426-1","volume":"21","author":"S Aroui","year":"2020","unstructured":"Aroui S, Fetoui H, Kenani A. Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesis. BMC Pharmacol Toxicol. 2020;21:1\u201310.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"19","key":"3090_CR116","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1039\/C1CC10778J","volume":"47","author":"Y Yang","year":"2011","unstructured":"Yang Y, et al. A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-\u03b2 ligand\u2013receptor binding. Chem Commun. 2011;47(19):5440\u20132.","journal-title":"Chem Commun"},{"issue":"10","key":"3090_CR117","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1055\/s-0029-1240892","volume":"76","author":"N Duarte","year":"2010","unstructured":"Duarte N, et al. Phenolic compounds as selective antineoplasic agents against multidrug-resistant human cancer cells. Planta Med. 2010;76(10):975\u201380.","journal-title":"Planta Med"},{"issue":"23","key":"3090_CR118","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1038\/emboj.2011.393","volume":"30","author":"LY Tang","year":"2011","unstructured":"Tang LY, et al. Ablation of Smurf2 reveals an inhibition in TGF-\u03b2 signalling through multiple mono-ubiquitination of Smad3. EMBO J. 2011;30(23):4777\u201389.","journal-title":"EMBO J"},{"key":"3090_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.11.022","volume":"58","author":"J Lee","year":"2019","unstructured":"Lee J, Kim D-H, Kim JH. Combined administration of naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and p38 signaling pathway. Phytomedicine. 2019;58:152762.","journal-title":"Phytomedicine"},{"issue":"12","key":"3090_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050956","volume":"7","author":"C Lou","year":"2012","unstructured":"Lou C, et al. Naringenin decreases invasiveness and metastasis by inhibiting TGF-\u03b2-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS ONE. 2012;7(12):e50956.","journal-title":"PLoS ONE"},{"issue":"6","key":"3090_CR121","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12272-020-01247-w","volume":"43","author":"A Szurpnicka","year":"2020","unstructured":"Szurpnicka A, Kowalczuk A, Szterk A. Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action. Arch Pharm Res. 2020;43(6):593\u2013629.","journal-title":"Arch Pharm Res"},{"issue":"2","key":"3090_CR122","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3892\/ijo.2017.3838","volume":"50","author":"S Sch\u00f6tterl","year":"2017","unstructured":"Sch\u00f6tterl S, et al. Viscumins functionally modulate cell motility-associated gene expression. Int J Oncol. 2017;50(2):684\u201396.","journal-title":"Int J Oncol"},{"key":"3090_CR123","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000375425","volume-title":"Mistletoe: from mythology to evidence-based medicine","author":"S Sch\u00f6tterl","year":"2015","unstructured":"Sch\u00f6tterl S, Naumann U. Mistletoe compounds as anti-cancer drugs: effects and mechanisms in the treatment of glioblastoma. In: Mistletoe: from mythology to evidence-based medicine. Basel: Karger Publishers; 2015. p. 48\u201356."},{"issue":"10","key":"3090_CR124","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bcp.2012.07.018","volume":"84","author":"M Tillhon","year":"2012","unstructured":"Tillhon M, et al. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260\u20137.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3090_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2015.1129481","volume":"10","author":"H Li","year":"2016","unstructured":"Li H, et al. The tumor microenvironment: an irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis. Cell Adhes Migr. 2016;10(4):1\u201313.","journal-title":"Cell Adhes Migr"},{"issue":"7","key":"3090_CR126","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.1002\/jcp.27835","volume":"234","author":"C Huang","year":"2019","unstructured":"Huang C, et al. Berberine reversed the epithelial-mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in the TGF-\u03b2 pathway. J Cell Physiol. 2019;234(7):11679\u201391.","journal-title":"J Cell Physiol"},{"key":"3090_CR127","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbrc.2022.07.101","volume":"625","author":"Y Sun","year":"2022","unstructured":"Sun Y, et al. Berberine inhibits glioma cell migration and invasion by suppressing TGF-\u03b21\/COL11A1 pathway. Biochem Biophys Res Commun. 2022;625:38\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"3090_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","volume":"125","author":"N Bhagya","year":"2016","unstructured":"Bhagya N, Chandrashekar K. Tetrandrine\u2013a molecule of wide bioactivity. Phytochemistry. 2016;125:5\u201313.","journal-title":"Phytochemistry"},{"key":"3090_CR129","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.foodres.2017.10.028","volume":"103","author":"L L\u00f3pez-Hortas","year":"2018","unstructured":"L\u00f3pez-Hortas L, et al. Recent developments on the extraction and application of ursolic acid. A review. Food Res Int. 2018;103:130\u201349.","journal-title":"Food Res Int"},{"issue":"3","key":"3090_CR130","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/cvr\/cvq082","volume":"87","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia\/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res. 2010;87(3):431\u20139.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"3090_CR131","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BSR20100065","volume":"31","author":"G Mudduluru","year":"2011","unstructured":"Mudduluru G, et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185\u201397.","journal-title":"Biosci Rep"},{"issue":"1\u20133","key":"3090_CR132","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000101316","volume":"185","author":"J Zavadil","year":"2007","unstructured":"Zavadil J, et al. Transforming growth factor-\u03b2 and microRNA: mrna regulatory networks in epithelial plasticity. Cells Tissues Organs. 2007;185(1\u20133):157\u201361.","journal-title":"Cells Tissues Organs"},{"key":"3090_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-14-2","volume":"14","author":"H Wang","year":"2015","unstructured":"Wang H, et al. NF-\u03baB induces miR-148a to sustain TGF-\u03b2\/Smad signaling activation in glioblastoma. Mol Cancer. 2015;14:1\u201314.","journal-title":"Mol Cancer"},{"key":"3090_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.768708","volume":"12","author":"X Xiong","year":"2021","unstructured":"Xiong X, et al. Insights into amentoflavone: a natural multifunctional biflavonoid. Front Pharmacol. 2021;12:768708.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3090_CR135","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1101\/gad.14.2.187","volume":"14","author":"M Bitzer","year":"2000","unstructured":"Bitzer M, et al. A mechanism of suppression of TGF\u2013\u03b2\/SMAD signaling by NF-\u03baB\/RelA. Genes Dev. 2000;14(2):187\u201397.","journal-title":"Genes Dev"},{"issue":"1","key":"3090_CR136","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4049\/jimmunol.176.1.603","volume":"176","author":"K-Y Lee","year":"2006","unstructured":"Lee K-Y, et al. NF-\u03baB and activator protein 1 response elements and the role of histone modifications in IL-1\u03b2-induced TGF-\u03b21 gene transcription. J Immunol. 2006;176(1):603\u201315.","journal-title":"J Immunol"},{"issue":"2","key":"3090_CR137","first-page":"92","volume":"11","author":"H-M Zhang","year":"2014","unstructured":"Zhang H-M, et al. Research progress on the anticarcinogenic actions and mechanisms of ellagic acid. Cancer Biol Med. 2014;11(2):92.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"3090_CR138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7314\/APJCP.2014.15.1.273","volume":"15","author":"T Zhang","year":"2014","unstructured":"Zhang T, et al. Ellagic acid exerts anti-proliferation effects via modulation of Tgf-\u03b2\/Smad3 signaling in MCF-7 breast cancer cells. Asian Pac J Cancer Prev. 2014;15(1):273\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"3090_CR139","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3892\/mmr.2024.13162","volume":"29","author":"W Zhang","year":"2024","unstructured":"Zhang W, et al. Pharmacological activity of capsaicin: mechanisms and controversies. Mol Med Rep. 2024;29(3):38.","journal-title":"Mol Med Rep"},{"key":"3090_CR140","first-page":"59","volume":"14","author":"NA Al-Dhabi","year":"2015","unstructured":"Al-Dhabi NA, et al. An up-to-date review of rutin and its biological and pharmacological activities. EXCLI J. 2015;14:59.","journal-title":"EXCLI J"},{"issue":"2","key":"3090_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/nu8020090","volume":"8","author":"DK Semwal","year":"2016","unstructured":"Semwal DK, et al. Myricetin: a dietary molecule with diverse biological activities. Nutrients. 2016;8(2):90.","journal-title":"Nutrients"},{"issue":"3","key":"3090_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091245","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen J, et al. Calycosin suppresses breast cancer cell growth via ER\u03b2-dependent regulation of IGF-1R, p38 MAPK and PI3K\/Akt pathways. PLoS ONE. 2014;9(3):e91245.","journal-title":"PLoS ONE"},{"issue":"39","key":"3090_CR143","doi-asserted-by":"publisher","first-page":"41722","DOI":"10.18632\/oncotarget.6152","volume":"6","author":"W-J Lu","year":"2015","unstructured":"Lu W-J, Chua M-S, So SK. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53-and p38-mediated apoptotic signaling. Oncotarget. 2015;6(39):41722.","journal-title":"Oncotarget"},{"key":"3090_CR144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5219-3","volume":"19","author":"J Li","year":"2019","unstructured":"Li J, et al. Prognostic value of TGF-\u03b2 in lung cancer: systematic review and meta-analysis. BMC Cancer. 2019;19:1\u20139.","journal-title":"BMC Cancer"},{"issue":"19","key":"3090_CR145","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.7314\/APJCP.2014.15.19.8143","volume":"15","author":"A-L Huang","year":"2014","unstructured":"Huang A-L, et al. TGF-\u03b21 protein expression in non-small cell lung cancers is correlated with prognosis. Asian Pac J Cancer Prev. 2014;15(19):8143\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3090_CR146","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10585-013-9598-1","volume":"30","author":"PF V\u00e1zquez","year":"2013","unstructured":"V\u00e1zquez PF, et al. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer. Clin Exp Metastasis. 2013;30:993\u20131007.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"3090_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67325-7","volume":"10","author":"BN Kim","year":"2020","unstructured":"Kim BN, et al. TGF-\u03b2 induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer. Sci Rep. 2020;10(1):10597.","journal-title":"Sci Rep"},{"key":"3090_CR148","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1245\/s10434-015-4804-9","volume":"22","author":"C-T Wu","year":"2015","unstructured":"Wu C-T, et al. TGF beta1 expression correlates with survival and tumor aggressiveness of prostate cancer. Ann Surg Oncol. 2015;22:1587\u201393.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3090_CR149","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajur.2015.04.011","volume":"2","author":"Z Cao","year":"2015","unstructured":"Cao Z, Kyprianou N. Mechanisms navigating the TGF-\u03b2 pathway in prostate cancer. Asian J Urol. 2015;2(1):11\u20138.","journal-title":"Asian J Urol"},{"key":"3090_CR150","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00109-014-1206-6","volume":"93","author":"C-T Wu","year":"2015","unstructured":"Wu C-T, et al. TGF-\u03b21 mediates the radiation response of prostate cancer. J Mol Med. 2015;93:73\u201382.","journal-title":"J Mol Med"},{"issue":"1","key":"3090_CR151","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1196\/annals.1386.024","volume":"1089","author":"MB Buck","year":"2006","unstructured":"Buck MB, Knabbe C. TGF-beta signaling in breast cancer. Ann N Y Acad Sci. 2006;1089(1):119\u201326.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3090_CR152","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1172\/JCI29293","volume":"117","author":"M Dong","year":"2007","unstructured":"Dong M, et al. The type III TGF-\u03b2 receptor suppresses breast cancer progression. J Clin Invest. 2007;117(1):206\u201317.","journal-title":"J Clin Invest"},{"issue":"12","key":"3090_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083521","volume":"8","author":"L Chakrabarti","year":"2013","unstructured":"Chakrabarti L, et al. A mechanism linking Id2-TGF\u03b2 crosstalk to reversible adaptive plasticity in neuroblastoma. PLoS ONE. 2013;8(12):e83521.","journal-title":"PLoS ONE"},{"issue":"11","key":"3090_CR154","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1172\/JCI69657","volume":"123","author":"EH Knelson","year":"2013","unstructured":"Knelson EH, et al. Type III TGF-\u03b2 receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. J Clin Investig. 2013;123(11):4786\u201398.","journal-title":"J Clin Investig"},{"issue":"1","key":"3090_CR155","first-page":"341","volume":"10","author":"Z Liu","year":"2017","unstructured":"Liu Z, Dong L, Dong Q. Microrna-203 inhibits proliferation and induces apoptosis of neuroblastoma SH-SY5Y cell via upregulation of TGF-\u03b21\/BIM signal. Int J Clin Exp Pathol. 2017;10(1):341\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"3090_CR156","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2146860","volume":"11","author":"K Louault","year":"2022","unstructured":"Louault K, et al. Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-\u03b2\/IL-6 pathway in neuroblastoma. Oncoimmunology. 2022;11(1):2146860.","journal-title":"Oncoimmunology"},{"key":"3090_CR157","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.brainres.2018.10.015","volume":"1704","author":"X-H Wang","year":"2019","unstructured":"Wang X-H, et al. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-\u03b21 induced LMO1 via control of let-7 expression. Brain Res. 2019;1704:219\u201328.","journal-title":"Brain Res"},{"issue":"8_Supplement","key":"3090_CR158","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1538-7445.AM2012-2290","volume":"72","author":"J Lynch","year":"2012","unstructured":"Lynch J, et al. MiR-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Cancer Res. 2012;72(8_Supplement):2290\u20132290.","journal-title":"Cancer Res"},{"issue":"1","key":"3090_CR159","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/abbs\/gmx127","volume":"50","author":"F Wu","year":"2018","unstructured":"Wu F, et al. Paradoxical roles of TGF-\u03b2 signaling in suppressing and promoting squamous cell carcinoma. Acta Biochim Biophys Sin. 2018;50(1):98\u2013105.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"28","key":"3090_CR160","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1038\/onc.2011.494","volume":"31","author":"Y Bian","year":"2012","unstructured":"Bian Y, et al. Loss of TGF-\u03b2 signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene. 2012;31(28):3322\u201332.","journal-title":"Oncogene"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03090-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03090-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03090-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T05:11:45Z","timestamp":1763788305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03090-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":160,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3090"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03090-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this study is a review article and does not involve the collection of data from human or animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}],"article-number":"529"}}